Answers are grounded in this paper and cite their sources.
This review explores the effects of SLRP-protease interactions on tissue integrity in various pathologies, suggesting potential diagnostic and therapeutic avenues.
Small leucine‐rich proteoglycans (SLRPs) are essential regulators of extracellular matrix (ECM) organization and cell signaling. Beyond their structural roles, SLRPs modulate protease activity or serve as their substrates, thereby influencing key physiological processes such as collagen fibrillogenesis, wound healing, skeletal development, and immune surveillance. On the other hand, the dysregulation of SLRP–protease interactions, in pathologies such as fibrosis, chronic inflammation, and cancer, results in aberrant ECM remodeling, immune activation, and altered cell behavior. Here, we review emerging insights into the functional crosstalk between SLRPs and proteases in health and disease. We highlight how these interactions impact tissue integrity and disease progression and explore their potential as diagnostic markers and therapeutic targets in fibrosis, cancer, and inflammatory disorders.
No takes yet. Share an insight, caveat, or question.
Konstantaraki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: